Germany bans promethazine prescriptions for young children over safety fears
Germany has introduced a new safety restriction on promethazine, a widely used medication. The drug will no longer be prescribed to children under six due to concerns over serious side effects. This decision follows a review by the country’s drug regulator, the Federal Institute for Drugs and Medical Devices (BfArM).
Promethazine is commonly prescribed as a sedative for agitation and psychiatric disorders. It also serves as an antihistamine for allergic reactions. Despite its long-standing use, the exact way it produces sedative or antipsychotic effects remains unclear. The drug belongs to the phenothiazine class and has anticholinergic, antiemetic, and strong H1-antihistamine properties.
The updated rules aim to reduce avoidable risks in young patients. Doctors and pharmacists will need to adjust prescriptions and inform parents about the change. Alternative treatments with better safety profiles are already available for the same conditions.
Read also:
- American teenagers taking up farming roles previously filled by immigrants, a concept revisited from 1965's labor market shift.
- Weekly affairs in the German Federal Parliament (Bundestag)
- Landslide claims seven lives, injures six individuals while they work to restore a water channel in the northern region of Pakistan
- Escalating conflict in Sudan has prompted the United Nations to announce a critical gender crisis, highlighting the disproportionate impact of the ongoing violence on women and girls.